Cited by 561Ovarian function and disordersMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Open access

Dunaif, A, Xia, J, Book, C B, Schenker, E, Tang, Z·1995·Journal of Clinical Investigation

DOI 10.1172/jci118126PMC PMC185266

Open this paper in CoChat — free account Open PDF

Abstract

We investigated the cellular mechanisms of the unique disorder of insulin action found in the polycystic ovary syndrome (PCOS). Approximately 50% of PCOS women (PCOS-Ser) had a significant increase in insulin-independent beta-subunit [32P]phosphate incorporation (3.7-fold, P < 0.05 vs other groups) in skin fibroblast insulin receptors that was present in serine residues while insulin-induced tyrosine phosphorylation was decreased (both P < 0.05 vs other groups). PCOS skeletal muscle insulin receptors had the same abnormal phosphorylation pattern. The remaining PCOS women (PCOS-n1) had basal and insulin-stimulated receptor autophosphorylation similar to control. Phosphorylation of the artificial substrate poly GLU4:TYR1 by the PCOS-Ser insulin receptors was significantly decreased (P < 0.05) compared to control and PCOS-n1 receptors. The factor responsible for excessive serine phosphorylation appeared to be extrinsic to the receptor since no insulin receptor gene mutations were identified, immunoprecipitation before autophosphorylation corrected the phosphorylation defect and control insulin receptors mixed with lectin eluates from affected PCOS fibroblasts displayed increased serine phosphorylation. Our findings suggest that increased insulin receptor serine phosphorylation decreases its protein tyrosine kinase activity and is one mechanism for the post-binding defect in insulin action characteristic of PCOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci118126

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L., Dull, T. J., Gray, A., Coussens, L. M., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Self-citation
Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.
Ullrich, A., Gray, A., Tam, A. W., Yang‐Feng, T. L., Tsubokawa, M., Collins, C. M., Henzel, W. J., Bon, T. L., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,843
[42] Detection and quantification of phosphotyrosine in proteins
Cooper, J. A., Sefton, B. M., & Hunter, T. R. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)99075-4 · Cited by 1,109
Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
POLSON, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 899
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624

Flagged first, then by citations

Show all 71 references

Sorted by citations

Items 101–200 of 559

Skeletal Muscle Insulin Resistance in Endocrine Disease
Peppa, Μ., Koliaki, C. C., Nikolopoulos, P., & Raptis, S. (2010) · BioMed Research International · doi:10.1155/2010/527850 · Cited by 129
The Role of Zinc in Selected Female Reproductive System Disorders
Nasiadek, M., Stragierowicz, J., Klimczak, M., & Kilanowicz, A. (2020) · Nutrients · doi:10.3390/nu12082464 · Cited by 129
Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
Lorenzo, M. D., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 149
Role of obesity and adiposity in polycystic ovary syndrome
Diamanti‐Kandarakis, E. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803730 · Cited by 129
The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome
van der Spuy, Z. M., & Dyer, S. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.06.001 · Cited by 127
Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome
Recabarren, S. E., Smith, R., Ríos, R., Maliqueo, M. A., Echiburú, B., Ethel Codner, D., CASSORLA, F. G., Rojas, P., & Sir‐Petermann, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2256 · Cited by 126
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis
Glintborg, D., Henriksen, J. E., Andersen, M., Hagen, C., Hangaard, J., Rasmussen, P. E., Schousboe, K., & Hermann, A. P. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.06.040 · Cited by 126
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Bril, F., Ezeh, U., Amiri, M., Hatoum, S., Pace, L., Chen, Y.-H., Bertrand, F., Gower, B., & Azziz, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad356 · Cited by 123
The genetics of polycystic ovary syndrome
Amato, P., & Simpson, J. L. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.05.002 · Cited by 122
Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation
Hsu, C., Shih, H.-Y., Chia, Y., Lee, C., Ashida, H., Lai, Y., & Weng, C. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300691 · Cited by 121
Syndromes of Severe Insulin Resistance
Tritos, N. A., & Mantzoros, C. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5143 · Cited by 120
Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance
Víctor, V. M., Rocha, M., Bañuls, C., Sánchez-Serrano, M., Solá, E., Gomez, M., & Hernández‐Mijares, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0466 · Cited by 120
Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols
Laganà, A. S., Rossetti, P., Buscema, M., Vignera, S. L., Condorelli, R. A., Gullo, G., Granese, R., & Triolo, O. (2016) · International Journal of Endocrinology · doi:10.1155/2016/6306410 · Cited by 112
Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators
Li, M., YOUNGREN, J. F., Dunaif, A. E., Goldfine, I. D., Maddux, B. A., Zhang, B. B., & Evans, J. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020363 · Cited by 110
Self-citation
Androgen excess is the key element in polycystic ovary syndrome
Azziz, R. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00735-0 · Cited by 109
Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS)
Diamanti‐Kandarakis, E., Argyrakopoulou, G., Economou, F., Kandaraki, E., & Koutsilieris, M. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.014 · Cited by 107
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome
Orio, F., Matarese, G., Biase, S. D., Palomba, S., Labella, D., Sanna, V., Savastano, S., Zullo, F., Colao, A., & Lombardi, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021816 · Cited by 106
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis
Chaudhary, H., Patel, J. K., Jain, N. K., & Joshi, R. G. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00879-w · Cited by 108
Polycystic ovarian disease: heritability and heterogeneity
Crosignani, P. G. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.1.3 · Cited by 107
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Tang, T. H., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub4 · Cited by 104
Protein kinase C modulates insulin action in human skeletal muscle
Cortright, R. N., Azevedo, J. L., Zhou, Q., Sinha, M. K., Pories, W. J., Itani, S. I., & Dohm, G. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e553 · Cited by 100
Association of acanthosis nigricans and skin tags with insulin resistance
Barbato, M. T., Criado, P. R., da Silva, A. K., Averbeck, E., Guerine, M. B., & de Sá, N. B. (2012) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962012000100012 · Cited by 99
The genetic basis of polycystic ovary syndrome
Xita, N. V., Georgiou, I. A., & Tsatsoulis, A. A. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470717 · Cited by 99
Polycystic Ovary Syndrome in Adolescence
Blank, S. K., Helm, K. D., McCartney, C. R., & Marshall, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.005 · Cited by 97
Disordered follicle development
Chang, R. J., & Cook‐Andersen, H. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.07.011 · Cited by 97
Oxidative stress and cardiovascular complications in polycystic ovarian syndrome
Hyderali, B. N., & Mala, K. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.005 · Cited by 96
Polycystic Ovary Syndrome in the Pediatric Population
Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 101
Reversal of Insulin Resistance Postpartum Is Linked to Enhanced Skeletal Muscle Insulin Signaling
Kirwan, J. P., Varastehpour, A., Jing, M. X., Presley, L. H., Shao, J., Friedman, J. E., & Catalano, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0749 · Cited by 97
Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity 1
Ciaraldi, T. P., Morales, A. J., Hickman, M. G., Odom-Ford, R., Olefsky, J. M., & Yen, S. S. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3961 · Cited by 96
Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome
Nilsson, E., Benrick, A., Kokosar, M., Krook, A., Lindgren, E., Källman, T., Martis, M. M., Højlund, K., Ling, C., & Stener-Victorin, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00935 · Cited by 93
MENSTRUAL DISORDERS IN ADOLESCENTS
Gordon, C. M. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70135-8 · Cited by 92
Endocrine causes of nonalcoholic fatty liver disease
Marino, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11053 · Cited by 93
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion ofPPAR- γ
Ünlütürk, U., Harmancı, A., Kocaefe, Ç., & Yıldız, B. O. (2007) · PPAR Research · doi:10.1155/2007/49109 · Cited by 92
Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome
Mukherjee, S., Shaikh, N. J., Khavale, S., Shinde, G., Meherji, P. K., Shah, N. S., & Maitra, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0932 · Cited by 94
Raised Serum, Adipocyte, and Adipose Tissue Retinol-Binding Protein 4 in Overweight Women with Polycystic Ovary Syndrome: Effects of Gonadal and Adrenal Steroids
Tan, B. K., Chen, J., Lehnert, H., Kennedy, R., & Randeva, H. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0091 · Cited by 90
Pathogenesis of polycystic ovary syndrome: what is the role of obesity?
Salehi, M., Bravo-Vera, R., Sheikh, A., Gouller, A., & Poretsky, L. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.005 · Cited by 90
Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS
Kalgaonkar, S., Almario, R. U., Gurusinghe, D., Garamendi, E. M., Buchan, W., Kim, K., & Karakas, S. E. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.266 · Cited by 88
Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston, E. J., & Templeman, N. M. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0269 · Cited by 93
Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome
Vargas, M. L., Almario, R. U., Buchan, W., Kim, K., & Karakas, S. E. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.007 · Cited by 86
Cardiometabolic features of polycystic ovary syndrome
Hoffman, L., & Ehrmann, D. A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0755 · Cited by 85
Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome
Moran, L., & Norman, R. J. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.05.003 · Cited by 84
Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment
Garruti, G., Depalo, R., Vita, M. G., Lorusso, F., Giampetruzzi, F., Damato, A. B., & Giorgino, F. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.05.010 · Cited by 82
Long term complications of polycystic ovary syndrome (PCOS)
Peigné, M., & Dewailly, D. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.07.111 · Cited by 81
New biomarkers for diagnosis and management of polycystic ovary syndrome
Karakas, S. E. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.009 · Cited by 81
Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome
Yılmaz, M., Bukan, N. C., Ersoy, R., Karakoç, A., Yetkin, İ., Ayvaz, G., Çakır, N., & Arslan, M. (2005) · Human Reproduction · doi:10.1093/humrep/dei070 · Cited by 81
The influence of obesity on hyperandrogenism and infertility in the female
Diamanti‐Kandarakis, E., & Bergiele, A. T. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00041.x · Cited by 82
POLYCYSTIC OVARY SYNDROME
Taylor, A. E. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70045-1 · Cited by 80
Stromal Cells of the Human Postmenopausal Ovary Display a Distinctive Biochemical and Molecular Phenotype
Jabara, S. I., Christenson, L. K., Wang, C. Y., McAllister, J. M., Javitt, N. B., Dunaif, A. E., & Strauss, J. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021274 · Cited by 79
Self-citation
Insulin Resistance and Metabolic Syndrome in the Pediatric Population
Nelson, R. A., & Bremer, A. A. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0068 · Cited by 81
Early steps in androgen biosynthesis: From cholesterol to DHEA
Miller, W. L. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80461-8 · Cited by 78
Insulin resistance in women with polycystic ovary syndrome
Dunaif, A. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.04.011 · Cited by 77
Self-citation
Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis
Kim, C. H., Chon, S. J., & Lee, S. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-64776-w · Cited by 76
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
Kempegowda, P., Melson, E., Manolopoulos, K. N., Arlt, W., & O’Reilly, M. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934319 · Cited by 78
The Relationship Between Polycystic Ovary Syndrome and Antiepileptic Drugs
Rasgon, N. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125745.60149.c6 · Cited by 73
Should patients with polycystic ovary syndrome be treated with metformin?: Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction
Stadtmauer, L. A. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3016 · Cited by 73
Phosphorylation of Human Cytochrome P450c17 by p38α Selectively Increases 17,20 Lyase Activity and Androgen Biosynthesis
Tee, M. K., & Miller, W. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.460048 · Cited by 72
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo‐controlled study in polycystic ovary syndrome
Glintborg, D., Frystyk, J., Højlund, K., Andersen, K. K., Henriksen, J. E., Hermann, A. P., Hagen, C., Flyvbjerg, A., & Andersen, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03015.x · Cited by 69
Impact of Obesity on Gynecology
Pandey, S., & Bhattacharya, S. (2010) · Women s Health · doi:10.2217/whe.09.77 · Cited by 70
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
Glintborg, D., Hermann, A. P., Andersen, M., Hagen, C., Beck‐Nielsen, H., Veldhuis, J. D., & Henriksen, J. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.067 · Cited by 68
Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome
Seow, K., Chang, Y.-W., Chen, K.-H., Juan, C., Huang, C.-Y., Lin, L.-T., Tsui, K.-H., Chen, Y., Lee, W.-L., & Wang, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218147 · Cited by 70
Zinc and Homocysteine Levels in Polycystic Ovarian Syndrome Patients with Insulin Resistance
Güler, İ., Himmetoğlu, Ö., Turp, A. B., Erdem, A., Erdem, M., Onan, M. A., Taşkıran, Ç., Taşlıpınar, M. Y., & Güner, H. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-9941-7 · Cited by 66
Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin Resistance
Allemand, M. C., Irving, B. A., Asmann, Y. W., Klaus, K. A., Tatpati, L., Coddington, C. C., & Nair, K. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004274 · Cited by 65
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study
Tang, T. H., Glanville, J., Hayden, C. J., White, D. M., Barth, J. H., & Balen, A. H. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000197800.07214.dc · Cited by 65
Prevention of diabetes and cardiovascular disease in women with PCOS: Treatment with insulin sensitizers
Sharma, S. T., & Nestler, J. E. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.003 · Cited by 64
Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls
Wu, X.-K., Sallinen, K., Anttila, L., Mäkinen, M., Luo, C., Pöllänen, P., & Erkkola, R. U. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00688-9 · Cited by 64
Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery
Seow, K., Juan, C., Hsu, Y.-P., Hwang, J., Huang, L., & Ho, L. (2007) · Human Reproduction · doi:10.1093/humrep/del466 · Cited by 64
Nutritional guidelines for the management of insulin resistance
Muscogiuri, G., Barrea, L., Caprio, M., Ceriani, F., Chavez, A. O., El Ghoch, M., Frias-Toral, E., Mehta, R. J., Mendez, V., Paschou, S. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1908223 · Cited by 63
New perspectives in polycystic ovary syndrome
Diamanti‐Kandarakis, E., & Dunaif, A. E. (1996) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00125-7 · Cited by 61
Self-citation
The molecular basis of premature adrenarche: an hypothesis
Miller, W. L. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb14405.x · Cited by 60
Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women
Sakumoto, T., Tokunaga, Y., Tanaka, H., Nohara, M., 茂木, 絵., Shinkawa, T., Nakaza, A., & Higashi, M. (2010) · Reproductive Medicine and Biology · doi:10.1007/s12522-010-0062-5 · Cited by 60
Ultra‐short metformin pretreatment for clomiphene citrate‐resistant polycystic ovary syndrome
Hwu, Y., Lin, S., Huang, W. Y., Lin, M., & Lee, R. K. K. (2005) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2005.04.004 · Cited by 60
Metabolic syndrome in women with polycystic ovary syndrome
Chandrasekaran, S., & Sagili, H. (2018) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12519 · Cited by 61
Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
Checa, M. Á., Requena, A., Salvador, C., Tur, R., Callejo, J., Espinós, J. J., Fábregues, F., Herrero, J. C., & (Reproductive Endocrinology Interest Group of the Spanish Society of Fertility) (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi015 · Cited by 60
DECREASES IN OVARIAN CYTOCHROME P450c17 a ACTIVITY AND SERUM FREE TESTOSTERONE AFTER REDUCTION OF INSULIN SECRETION IN POLYCYSTIC OVARY SYNDROME
Estler, J. O. E. N., & Akubowicz, A. J. J. (2011) · Cited by 59
Insulin resistance in patients with polycystic ovary syndrome
Schröder, A. K., Tauchert, S., Ortmann, O., Diedrich, K., & Weiss, J. M. (2004) · Annals of Medicine · doi:10.1080/07853890410035296 · Cited by 59
Insulin Resistance, Polycystic Ovary Syndrome and Metformin
PUGEAT, M. M., & Ducluzeau, P. (1999) · Drugs · doi:10.2165/00003495-199958001-00010 · Cited by 59
High prevalence of metabolic syndrome among young women with premature coronary artery disease
Turhan, H., Yaşar, A. S., Başar, N., Biçer, A., Erbay, A. R., & Yetkın, E. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200502000-00007 · Cited by 57
Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and θ
Strack, V., Hennige, A. M., Krützfeldt, J., Bossenmaier, B., Klein, H. H., Kellerer, M., Lammers, R., & Häring, H. (2000) · Diabetologia · doi:10.1007/s001250051327 · Cited by 56
The Development of the Polycystic Ovary Syndrome: Family History as a Risk Factor
Kahsar-Miller, M., & Azziz, R. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00021-6 · Cited by 56
Pathways Leading to Phosphorylation of P450c17 and to the Posttranslational Regulation of Androgen Biosynthesis
Tee, M. K., Dong, Q., & Miller, W. L. (2008) · Endocrinology · doi:10.1210/en.2007-1527 · Cited by 55
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 55
Elevated Chemerin Induces Insulin Resistance in Human Granulosa-Lutein Cells from Polycystic Ovary Syndrome Patients
Li, X., Zhu, Q., Wang, W., Qi, J., He, Y., Wang, Y., Lu, Y., Wu, H., Ding, Y., & Sun, Y. W. (2018) · The FASEB Journal · doi:10.1096/fj.201802829r · Cited by 54
Genetic and environmental aspect of polycystic ovary syndrome
Carmina, E. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345266 · Cited by 54
Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo
Rajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz‐Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J. R., & Sutherland, C. D. (2008) · Biochemical Journal · doi:10.1042/bj20082176 · Cited by 56
Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
Ciotta, L., Calogero, A. E., Farina, M., Leo, V. D., Marca, A. L., & Cianci, A. (2001) · Human Reproduction · doi:10.1093/humrep/16.10.2066 · Cited by 54
Obesity and Polycystic Ovary Syndrome
Kim, J. (2024) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes24035 · Cited by 53
Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?
Holte, J. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350784 · Cited by 52
Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome
Dokras, A., Jagasia, D. H., Maifeld, M., Sinkey, C. A., Voorhis, B. J. V., & Haynes, W. G. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.038 · Cited by 52
Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
Miller, W. L. (2005) · Medical Principles and Practice · doi:10.1159/000086185 · Cited by 53
The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome
Corbould, A. M., & Dunaif, A. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.021 · Cited by 52
Self-citation
Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries
Yen, H.-W. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah066 · Cited by 52
Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling
Azziz, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021131 · Cited by 52
Therapeutic effects and molecular mechanisms of quercetin in gynecological disorders
Jian, X., Chen, S., Luo, W., Zhou, L., Jiang, L., & Liu, K. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116418 · Cited by 51
Current perspectives in polycystic ovary syndrome.
Richardson, M. R. (2003) · PubMed · Cited by 51
The role of genes in the polycystic ovary syndrome: Predisposition and mechanisms
Deligeoroglou, E., Kouskouti, C., & CHRISTOPOULOS, P. F. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015619 · Cited by 50
Regulation of Steroidogenesis
Bremer, A. A., & Miller, W. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00013-5 · Cited by 54
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Tang, T. H., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub3 · Cited by 51
Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: A retrospective analysis
Sharma, S. T., Wickham, E. P., & Nestler, J. E. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.373 · Cited by 49

Authors: Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z.
Affiliations: Pennsylvania State University (US)
ORCID: Dunaif, A
Schenker, E
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1995-08-01
Volume: 96
Issue: 2
Pages: 801-810
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci118126
PMC: PMC185266
OpenAlex: W2124838987
Cited by: 561
References: 71
Citations by year: 2026: 3 · 2025: 15 · 2024: 7 · 2023: 17 · 2022: 20 · 2021: 18 · 2020: 15 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 8 · 2015: 19 · 2014: 18 · 2013: 23 · 2012: 21
FWCI: 18.65
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605, R01 DK-40605)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, insulin resistance, insulin receptor, serine phosphorylation, tyrosine phosphorylation, receptor autophosphorylation, protein tyrosine kinase activity, dermal fibroblasts, skeletal muscle, insulin signaling
MeSH terms: Adult, Blood Glucose, Cells, Cultured, Diabetes Mellitus, Type 2, Female, Fibroblasts, Humans, Insulin, Insulin Resistance, Obesity, Peptides, Phosphorylation, Phosphoserine, Polycystic Ovary Syndrome, Protein Processing, Post-Translational, Receptor, Insulin, Skin, Protein Serine-Threonine Kinases, Muscle, Skeletal, Intercellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks